Subtype
Colon Neoplasm
CI-CAN-00004992Explore in graph →
Non-malignant272 active trials5 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004992Explore in graph →
Clinical trials
1,561 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01972737 | Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer | completed | Phase 1 | 10 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT02632448 | A Study of LY2880070 in Participants With Advanced or Metastatic Cancer | completed | Phase 1 / Phase 2 | 229 | Esperas Pharma Inc.OTHER | 4 | May 2, 2025 | clinicaltrials |
| NCT06573424 | Tirellizumab+Anlotinib VS Anlotinib for MSS-type CRC | completed | — | 124 | fan liOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT06950996 | A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum | completed | — | 300 | Instituto de Investigacion Sanitaria La FeOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT04713007 | Improving Quality of Life for Colon Cancer Patients and Their Caregivers | active not recruiting | N/A | 60 | University of HawaiiOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT03428477 | EPA for Metastasis Trial 2(EMT2) | active not recruiting | Phase 3 | 418 | Mark A Hull, PhD FRCPOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT05500248 | Artificial Intelligence for Leaving in Situ Colorectal Polyps. | completed | N/A | 919 | University of Roma La SapienzaOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT02990481 | A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | Toray Industries, IncINDUSTRY | 2 | Apr 16, 2025 | clinicaltrials |
| NCT06324409 | ImmigrantScreen Telephone Reminder Trial in Colorectal Cancer Screening | completed | N/A | 400 | Norwegian Institute of Public HealthOTHER_GOV | 1 | Apr 15, 2025 | clinicaltrials |
| NCT04441580 | Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in a Screening Setting(GENIAL-CO) | completed | N/A | 900 | Fondazione Poliambulanza Istituto OspedalieroOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT04980287 | Mesogastrium Metastasis in Colon Cancer | recruiting | — | 50 | Jichao QinOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT06910514 | Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions | completed | Phase 3 | 52 | Nakafarma S.L.INDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06920082 | Progressive Muscle Relaxation Exercises on Sleep, Fatigue and Pain in Pancreatic and Colon Cancer Patients | active not recruiting | N/A | 60 | Istanbul Sabahattin Zaim UniversityOTHER | 1 | Apr 9, 2025 | clinicaltrials |
| NCT04322539 | A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer(FRESCO-2) | completed | Phase 3 | 691 | Hutchison Medipharma LimitedINDUSTRY | 14 | Apr 4, 2025 | clinicaltrials |
| NCT04025541 | Analysis of Circulating Tumor Markers in Blood(ALCINA2) | recruiting | N/A | 992 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06293625 | Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70 Years Old or More(FOxTROT2France) | recruiting | Phase 3 | 150 | Centre Hospitalier Universitaire DijonOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT06443203 | Multimodal Prehabilitation in Colorectal Cancer Patients | active not recruiting | N/A | 112 | University Hospital of FerraraOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT04108481 | Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer(iRE-C) | terminated | Phase 1 | 5 | University of IowaOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT05390398 | Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention(SoFiT) | completed | N/A | 161 | Wageningen UniversityOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT06899477 | Pre-Operative Treatment in REseCTable COlon CanceR | not yet recruiting | Phase 3 | 714 | Dominik Paul ModestOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT06900686 | Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival | completed | — | 458 | Yanhong DengOTHER | 0 | Mar 28, 2025 | clinicaltrials |
| NCT01372696 | Endoscopic Characteristics of Colonic Tumours(C-LST) | withdrawn | N/A | 0 | Professor Michael BourkeOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT03506321 | Comparison of the Benefit of Chromoendoscopy in Addition to High Definition White Light and Narrow Band Imaging for the Prediction of Submucosal Invasive Cancer in Colonic Lesions(LANS) | completed | N/A | 400 | Western Sydney Local Health DistrictOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT04138030 | Conventional Endoscopic Mucosal Resection Versus Cold Snare Endoscopic Mucosal Resection of Colonic Lateral Spreading Lesions - A Randomised Controlled Trial | completed | N/A | 182 | Western Sydney Local Health DistrictOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT05041478 | Cold Snare Endoscopic Mucosal Resection (EMR) vs Cold EMR With Margin Snare Tip Soft Coagulation (STSC) | recruiting | N/A | 300 | Western Sydney Local Health DistrictOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT03200834 | Comparison of D2 vs D3 Lymph Node Dissection for Right Colon Cancer (RICON) | active not recruiting | N/A | 239 | G.V. Bondar Republican Cancer CenterOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT05347745 | Therascreen® KRAS RGQ PCR Kit | completed | N/A | 219 | QIAGEN Gaithersburg, IncINDUSTRY | 1 | Mar 24, 2025 | clinicaltrials |
| NCT05686499 | Building Capacity for Screening & Early Diagnosis of Colorectal Cancer Through a Comprehensive Colonoscopy Training Program in Nigeria | recruiting | N/A | 20 | Obafemi Awolowo University Teaching HospitalOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT00200200 | Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer | completed | Phase 2 | 73 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT05179837 | Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps | terminated | N/A | 36 | Washington University School of MedicineOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06790212 | Neoadjuvant CAPOX Plus Ivonescimab Versus CAPOX for Locally Advanced Colon Cancer | not yet recruiting | Phase 2 | 168 | Sun Yat-sen UniversityOTHER | 0 | Mar 17, 2025 | clinicaltrials |
| NCT04701853 | Specific Training After Stoma Surgery(STASS) | recruiting | N/A | 240 | Göteborg UniversityOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT06865586 | A Comparative Study of Tumor Specific Mesocolic Excision and Complete Mesocolic Excision for Right Sided Colon Cancer : Asian Multicenter Retrospective Study | completed | — | 3,326 | Asan Medical CenterOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT06852495 | the Effect of Environmental Factors on Colorectal Cancer Based on Macrogenomes | active not recruiting | — | 200 | Dong PengOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT03058289 | A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6(IT-01) | completed | Phase 1 / Phase 2 | 111 | Intensity Therapeutics, Inc.INDUSTRY | 2 | Feb 27, 2025 | clinicaltrials |
| NCT06703632 | Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection(MS-Prevecol) | recruiting | N/A | 4,538 | ADVANCED MARKER DISCOVERY S.L.INDUSTRY | 2 | Feb 27, 2025 | clinicaltrials |
| NCT06843954 | Impact of Vascular Endothelial Growth Factor Gene Polymorphisms on Bevacizumab Efficacy in a Sample of Iraqi Patients With Metastatic Colorectal Cancer | completed | Phase 4 | 157 | Mohammed Mahmood MohammedOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT04213794 | Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients(TOASTIT) | terminated | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Feb 20, 2025 | clinicaltrials |
| NCT04906343 | Endoscopic Surveillance in Serrated Polyposis Syndrome and Low-risk of Advanced Neoplasia | completed | N/A | 144 | Hospital Universitario de MóstolesOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT03255434 | LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy(LEANOX) | active not recruiting | Phase 2 | 160 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT03992664 | Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. | completed | N/A | 40 | Cyprus University of TechnologyOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT05257135 | A Clinico-biological Database in Cachexia in Patients With Colon Cancer(BCBCachexie) | recruiting | N/A | 150 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT04186117 | Development of Clinical and Biological Database in Colorectal Cancer(CIRCUS) | completed | N/A | 89 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT05472753 | Dietary Supplement on the Intestinal Microbiota in Patients with Colon Cancer(TERATROFO) | completed | N/A | 75 | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT06640166 | Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.(ECLYPse) | recruiting | Phase 2 | 25 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT02861430 | Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology(UNMASK) | completed | — | 48 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT01652196 | Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer | completed | Phase 2 | 56 | John HaysOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT01814501 | Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab | completed | Phase 2 | 16 | John HaysOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT03764137 | Imaging with [89Zr]Panitumumab-PET/MRI in Patients with Newly Diagnosed Colorectal Cancer(Panitumumab) | withdrawn | Phase 1 / Phase 2 | 0 | University of Alabama at BirminghamOTHER | 0 | Jan 31, 2025 | clinicaltrials |
| NCT04046445 | Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer(KISIMA-01) | active not recruiting | Phase 1 | 96 | Amal TherapeuticsINDUSTRY | 4 | Jan 29, 2025 | clinicaltrials |
Data updated 24 days agoSource updated May 2, 2025source: clinicaltrials